-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, CCH9NLKJs84GDSLQcwNXyK9elUj/QduTYY9jKOBY2gtEF5wTZc6dHa46P5VP2Zcm a8kmx6jcJtli8hECa28bbA== 0001019687-02-000167.txt : 20020414 0001019687-02-000167.hdr.sgml : 20020414 ACCESSION NUMBER: 0001019687-02-000167 CONFORMED SUBMISSION TYPE: SC 13G/A PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20020208 SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: CYPRESS BIOSCIENCE INC CENTRAL INDEX KEY: 0000716054 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 222389839 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13G/A SEC ACT: 1934 Act SEC FILE NUMBER: 005-35589 FILM NUMBER: 02530393 BUSINESS ADDRESS: STREET 1: 4350 EXECUTIVE DRIVE,SUITE 325 CITY: SAN DIEGO STATE: CA ZIP: 92121 BUSINESS PHONE: 2062989400 MAIL ADDRESS: STREET 1: 401 QUEEN ANNE AVE NORTH CITY: SEATTLE STATE: WA ZIP: 98109 FORMER COMPANY: FORMER CONFORMED NAME: IMRE CORP DATE OF NAME CHANGE: 19920703 FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: KRANZLER JAY D CENTRAL INDEX KEY: 0001055666 FILING VALUES: FORM TYPE: SC 13G/A BUSINESS ADDRESS: STREET 1: 4350 EXECUTIVE DRIVE STREET 2: SUITE 325 CITY: SAN DIEGO STATE: CA ZIP: 92121 BUSINESS PHONE: 6194522323 MAIL ADDRESS: STREET 1: 4350 EXECUTIVE DRIVE STREET 2: SUITE 325 CITY: SAN DIEGO STATE: CA ZIP: 92121 SC 13G/A 1 kranzler_13ga3-123101.txt UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 13G UNDER THE SECURITIES EXCHANGE ACT OF 1934 (AMENDMENT NO. 3)* CYPRESS BIOSCIENCE, INC. ------------------------ (Name of Issuer) COMMON STOCK, $.02 PAR VALUE PER SHARE -------------------------------------- (Title of Class of Securities) 232674 10 1 ----------- (CUSIP Number) 12/31/01 -------- (Date of Event Which Requires Filing of This Statement) Check the appropriate box to designate the rule pursuant to which this Schedule is filed: |_| Rule 13d-1(b) |_| Rule 13d-1(c) |X| Rule 13d-1(d) *The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page. The information required in the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes). Page 1 of 4 pages --------------------- ------------------ CUSIP NO. 232674 10 1 13G PAGE 2 OF 4 PAGES --------------------- ------------------ ________________________________________________________________________________ 1. NAME OF REPORTING PERSONS I.R.S. IDENTIFICATION NO. OF ABOVE PERSONS (ENTITIES ONLY) JAY D. KRANZLER ________________________________________________________________________________ 2. CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP* (a) [_] (b) [_] ________________________________________________________________________________ 3. SEC USE ONLY ________________________________________________________________________________ 4. CITIZENSHIP OR PLACE OF ORGANIZATION UNITED STATES ________________________________________________________________________________ NUMBER OF 5. SOLE VOTING POWER SHARES 557,974 (1) _________________________________________________________________ BENEFICIALLY 6. SHARED VOTING POWER OWNED BY 0 _________________________________________________________________ EACH 7. SOLE DISPOSITIVE POWER REPORTING 514,161 (2) _________________________________________________________________ PERSON 8. SHARED DISPOSITIVE POWER WITH 0 ________________________________________________________________________________ 9. AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 557,974 ________________________________________________________________________________ 10. CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES* [_] ________________________________________________________________________________ 11. PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9) 8.3% ________________________________________________________________________________ 12. TYPE OF REPORTING PERSON* IN ________________________________________________________________________________ *SEE INSTRUCTIONS BEFORE FILLING OUT! Page 2 of 15 (1) Includes (a) 409,718 shares issuable to Reporting Person upon exercise of options to purchase common stock within 60 days of December 31, 2001, and (b) 43,813 shares held in the Issuer's 401(k) Plan, of which the Reporting Person is a trustee. The Reporting Person disclaims beneficial ownership of the 43,813 shares, and this report shall not be deemed an admission that the reporting person is the beneficial owner of such securities. (2) Excludes the 43,813 shares held in the issuer's 401(k) Plan, of which the reporting person does not have dispositive power. Page 2 of 4 pages ITEM 1(a). Name of Issuer: Cypress Bioscience, Inc., a Delaware corporation ------------------------------------------------ ITEM 1(b). Address of Issuer's Principal Executive Offices: 4350 Executive Drive, Suite 325 ------------------------------- San Diego, CA 92121 -------------------- ITEM 2(a). Name of Person Filing: Jay D. Kranzler --------------- ITEM 2(b). Address of Principal Business Office or, if none, Residence: 4350 Executive Drive, Suite 325 ------------------------------- San Diego, CA 92121 -------------------- ITEM 2(c). Citizenship: United States ------------- ITEM 2(d). Title of Class of Securities: Common Stock ------------ ITEM 2(e). CUSIP Number: 232674 10 1 ----------- ITEM 3. NOT APPLICABLE. ITEM 4. OWNERSHIP. (a) Amount Beneficially Owned: 557,974 shares, including (i) 409,718 shares issuable to Reporting Person upon exercise of options to purchase Common Stock within 60 days of 12/31/01, and (ii) 43,813 shares held in the Issuer's 401(k) Plan, of which the Reporting person is the trustee. (b) Percent of Class: 8.3% (c) Number of shares as to which such person has: (i) sole power to vote or to direct the vote: 557,974 (ii) shared power to vote or to direct the vote: 0 (iii) sole power to dispose or to direct the disposition of: 514,161 (iv) shared power to dispose or to direct the disposition of: 0 Page 3 of 4 pages ITEM 5. OWNERSHIP OF FIVE PERCENT OR LESS OF A CLASS. If this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner of more than five percent of the class of securities, check the following: [ ] ITEM 6. OWNERSHIP OF MORE THAN FIVE PERCENT ON BEHALF OF ANOTHER PERSON. Not applicable ITEM 7. IDENTIFICATION AND CLASSIFICATION OF THE SUBSIDIARY WHICH ACQUIRED THE SECURITY BEING REPORTED ON BY THE PARENT HOLDING COMPANY. Not applicable. ITEM 8. IDENTIFICATION AND CLASSIFICATION OF MEMBERS OF THE GROUP. Not applicable. ITEM 9. NOTICE OF DISSOLUTION OF GROUP. Not applicable. ITEM 10. CERTIFICATION. Not applicable SIGNATURE After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct. February 7, 2002 ------------------------------------- Date /s/ Jay D. Kranzler ------------------------------------- Signature Jay D. Kranzler ------------------------------------- Printed Name Page 4 of 4 pages -----END PRIVACY-ENHANCED MESSAGE-----